Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease
Authors:
Emily M Harris, Emily Vilk, Carolina Donado, Alexis Williams, Matthew M Heeney, Jean Solodiuk, Christine Greco, Natasha M Archer
Published:
02 March 2023
Previous
Previous
Sickle cell disease: time to act on the most neglected global health problem
Next
Next